India markets closed

uniQure N.V. (QURE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
32.87-1.63 (-4.72%)
At close: 4:00PM EDT
34.85 +1.98 (6.02%)
After hours: 04:16PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close34.50
Open34.01
Bid31.40 x 800
Ask37.87 x 1100
Day's range32.78 - 34.93
52-week range28.58 - 71.45
Volume1,032,124
Avg. volume435,147
Market cap1.51B
Beta (5Y monthly)1.27
PE ratio (TTM)N/A
EPS (TTM)-3.10
Earnings date28-Jul-2021 - 02-Aug-2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est67.29
  • uniQure Announces Enrollment of First Two Patients in Second Cohort of Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease
    GlobeNewswire

    uniQure Announces Enrollment of First Two Patients in Second Cohort of Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease

    LEXINGTON, Mass. and AMSTERDAM, The Netherlands, June 16, 2021 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that the first two patient procedures have been completed in the higher dose, second cohort of the Phase I/II clinical trial of AMT-130 for the treatment of Huntington’s disease. The initiation of patient enrollment in this 16-patient cohort follows a meeting last m

  • UPDATE -- uniQure to Participate in Multiple Upcoming Industry Conferences in June
    GlobeNewswire

    UPDATE -- uniQure to Participate in Multiple Upcoming Industry Conferences in June

    ~ uniQure to host virtual Research & Development Day on June 22, 2021 ~LEXINGTON, Mass. and AMSTERDAM, June 02, 2021 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced its participation in the following upcoming virtual investor and scientific conferences: Jefferies Virtual Healthcare Conference, June 1 - 4, 2021 Members of uniQure’s management team will participate in virtual

  • uniQure to Participate in Multiple Upcoming Industry Conferences in June
    GlobeNewswire

    uniQure to Participate in Multiple Upcoming Industry Conferences in June

    ~ uniQure to host virtual Research & Development Day on June 22, 2021 ~LEXINGTON, Mass. and AMSTERDAM, June 02, 2021 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced its participation in the following upcoming virtual investor and scientific conferences: Jefferies Virtual Healthcare Conference, June 1 - 4, 2021 Members of uniQure’s management team will participate in virtual